Faheem Hasnain
President & CEO at Gossamer Bio Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Gossamer Bio Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Gossamer Bio Inc. June 4, 202677.6%
-
Kura Oncology Inc. June 5, 202489.1%
-
Gossamer Bio Inc. June 8, 202390.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Aspen Neuroscience Inc. | Grant or award | +321,672 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +14,913 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +14,316 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +7,120 | — | — |
| Jan 2, 2026 | Gossamer Bio Inc. | Grant or award | +280,000 | — | — |
| Dec 9, 2025 | Kura Oncology Inc. | Option exercise | +10,000 | $3.12 | $31,200 |
| Dec 9, 2025 | Kura Oncology Inc. | Open-market sale | −10,000 | $10.98 | $109,800 |
| Oct 1, 2025 | Gossamer Bio Inc. | Grant or award | +437,500 | — | — |
| Mar 21, 2025 | Kura Oncology Inc. | Option exercise | +22,682 | $6.32 | $143,350 |
| Mar 21, 2025 | Kura Oncology Inc. | Open-market sale | −22,682 | $8.00 | $181,456 |
| Jun 21, 2024 | Gossamer Bio Inc. | Open-market purchase | +372,000 | $0.67 | $249,240 |
| Mar 27, 2024 | Gossamer Bio Inc. | Open-market sale | −23,172 | $1.16 | $26,880 |
| Jul 24, 2023 | Gossamer Bio Inc. | Grant or award | +540,176 | $1.82 | $983,120 |
| Mar 22, 2023 | Gossamer Bio Inc. | Open-market purchase | +440,500 | $1.14 | $502,170 |
| Mar 21, 2023 | Gossamer Bio Inc. | Open-market purchase | +269,389 | $1.20 | $323,267 |
Questions about Faheem Hasnain
What boards is Faheem Hasnain on?
Faheem Hasnain sits on the boards of Aspen Neuroscience Inc., Gossamer Bio Inc. and Kura Oncology Inc.
What company is Faheem Hasnain the CEO of?
Faheem Hasnain is President & CEO of Gossamer Bio Inc.
How long has Faheem Hasnain served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.